Steve Passin's column in the December issue of Medical Meetings is a good look at what CME providers are finding perplexing about the ACCME's new Standards for Commercial Support, along with his take on how to figure out what they mean. I highly...
First there was the whole Vioxx and Celebrex thing. And now there's a new twist on an old drug: The FDA is doing a pilot study on the use of Ecstasy (methylenedioxymethamphetamine), better known for showing up in dance clubs than hospices, to help...